RemedyMD Announces Selection of ComprehensiveBMT(TM), New Hematopoietic Stem Cell Transplant and Research Reporting System, by Huntsman Cancer Institute
First Commercially Available Software That Enables Electronic Submission of CIBMTR Forms Through AGNIS System
(firmenpresse) - SALT LAKE CITY, UT -- (Marketwire) -- 11/17/11 -- RemedyMD announced today that the Huntsman Cancer Institute (HCI) at the University of Utah has selected its ComprehensiveBMT™ Hematopoietic Stem Cell Transplant (HSCT) research and reporting system. Designed to solve the most vexing data management and reporting challenges of HSCT centers, ComprehensiveBMT will allow researchers to:
Submit CIBMTR forms faster and more efficiently
Automatically generate ASBMT RFI Forms
Facilitate FACT accreditation with document management tools
Aggregate data from disparate sources into a clinical registry
Capture longitudinal patient data through a web-based patient portal
Modify electronic data capture forms quickly and easily
Identify patterns with cutting-edge data visualization tools
"We are thrilled that HCI selected ComprehensiveBMT. Even more than the increased reporting and data management efficiencies, we think the ability to analyze and visualize patient data submitted to CIBMTR will be extremely valuable from a research and outcomes tracking standpoint," said Dr. Jonathan Dewey, Clinical Director at RemedyMD.
Dr. Michael Boyer, Interim Director of the University of Utah Blood and Marrow Transplant Program, commented, "ComprehensiveBMT was the obvious solution to our data needs. The ability to submit CIBMTR forms quickly and easily was a key feature that distinguished the software from the competition. We've also been extremely impressed with the data visualization tools and the ability to easily customize forms and reports for our specific needs."
"We've made a significant effort to develop the required CIBMTR Forms and the AGNIS interfaces necessary to enable submission of these forms quickly and easily through ComprehensiveBMT," said Gary Kennedy, RemedyMD's Founder & CEO. "We are grateful for the cooperation we have received from Dr. Rizzo and the technical team at CIBMTR as we've worked on this project. With their assistance, we have been able to complete the interface for sending data for the first of these forms and expect that over the next few weeks we will complete the interfaces for sending and retrieving data for the remaining forms."
"The Huntsman Cancer Institute has successfully submitted CIBMTR Form data to the AGNIS system through the ComprehensiveBMT software. CIBMTR is encouraged by this use of the AGNIS application to exchange data with the CIBMTR. It represents one of the many ways the AGNIS application can facilitate automated data exchange using the library of standard data elements and the messaging system that CIBMTR has developed in the last several years," said Dr. Douglas Rizzo, CIBMTR's Associate Scientific Director for Data Operations and CIBMTR Executive Committee member.
RemedyMD is the leading provider of registries and registry-based applications for life science research. RemedyMD's disease registry software is cutting edge healthcare IT software which enables researchers, clinicians and scientists to collect, aggregate, harmonize, and analyze data from widely disparate sources and then use Mosaic™ Platform tools and applications to identify patterns that result in accelerated discoveries and better clinical data management. For more information visit: .
CONTACT:
Kristofer Beldin
RemedyMD
801-870-9407
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 17.11.2011 - 07:15 Uhr
Sprache: Deutsch
News-ID 1058099
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SALT LAKE CITY, UT
Phone:
Kategorie:
Hospitals, Facilities and Providers
Anmerkungen:
Diese Pressemitteilung wurde bisher 91 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"RemedyMD Announces Selection of ComprehensiveBMT(TM), New Hematopoietic Stem Cell Transplant and Research Reporting System, by Huntsman Cancer Institute
"
steht unter der journalistisch-redaktionellen Verantwortung von
RemedyMD (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
